Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, TDS, TRI

Alligator Bioscience to Present at the 10th Annual Biotech Showcase Conference


LUND, Sweden, Jan. 4, 2018 /PRNewswire/ --

Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing tumor-directed immunotherapies, today announced that the company is scheduled to present at the 10th Annual Biotech Showcase conference held 8-10 January, 2018 in San Francisco, US.

Chief Executive Officer Per Norlén will give an update on the company's clinical stage project ADC-1013, out-licensed to Janssen Biotech Inc., as well as the near-clinical bispecific antibody ATOR-1015 and the preclinical projects ALG.APV-527 and ATOR-1017.

The presentation will take place on 8 January, at 10:30 a.m. PST /8 Jan 7:30 p.m. CET. The audio and slide presentation will be webcasted live and can be accessed via the Alligator web site. To access the presentation, live and replay, please go to https://event.webcasts.com/starthere.jsp?ei=1175723&tp_key=101995f0f8.

The information was submitted for publication, through the agency of the contact person set out above, at 11:00 a.m. CET on 4 January 2018.

About Alligator Bioscience
Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immunotherapies. Alligator's growing pipeline includes four lead clinical and pre-clinical therapeutic antibodies (ADC-1013, ATOR-1015, ATOR-1017 and ALG.APV-527). ADC-1013 (JNJ-64457107) is licensed to Janssen Biotech, Inc., part of J&J, for global development and commercialization. Alligator's shares are listed on Nasdaq Stockholm (ATORX). The Company is headquartered in Lund, Sweden, and has approximately 50 employees. For more information, please visit www.alligatorbioscience.com.

For further information, please contact:
Cecilia Hofvander,
Director Investor Relations & Communications
Phone +46-46-286-44-95
E-mail: [email protected]

This information was brought to you by Cision http://news.cision.com
http://news.cision.com/alligator-bioscience/r/alligator-bioscience-to-present-at-the-10th-annual-biotech-showcase-conference,c2425257

The following files are available for download:

http://mb.cision.com/Main/12681/2425257/773833.pdf

Alligator Bioscience to Present at the 10th Annual Biotech Showcase Conference

 


These press releases may also interest you

at 17:00
SpryPoint, the leading enterprise software-as-a-service (SaaS) provider to Utilities across North America, is proud to announce the upcoming release of SpryWallet, an embedded payment solution designed specifically for the SpryCIS and SpryEngage...

at 16:55
Veterinary Management Groups (VMG) is proud to...

at 16:53
telMAX broke ground today in Richmond Hill with the commencement of a state-of-the-art fibre Internet infrastructure project that will deliver all-fibre Internet connectivity to residents and businesses throughout the community....

at 16:35
Bragg Gaming Group Inc. ("Bragg" or the "Company"), a global B2B gaming technology and content provider, today announced the issuance of a secured promissory note in the principal amount of US$7 million (the "Note") to certain entities controlled by...

at 16:30
Scienjoy Holding Corporation ("Scienjoy", the "Company", or "we") , an interactive entertainment leader in the Chinese market, today announced its financial results for the year ended December 31, 2023. Fiscal Year 2023 Operating and Financial...

at 16:30
Farmmi, Inc. ("Farmmi" or the "Company") , an agriculture products supplier in China, today announced that on April 22, 2024, it received a letter from The Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that it is currently not in...



News published on and distributed by: